DOI:
10.1055/s-00033990
TH Open
LinksClose Window
References
Yao X, Abraham NS, Sangaralingham LR. et al.
Effectiveness and safety of dabigatran, rivaroxaban, and apixaban versus warfarin in nonvalvular atrial fibrillation.
J Am Heart Assoc 2016;
5 (06) e003725
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.